Approval · Notice of Compliance 26710 · 2021

MEGESTROL: Notice of Compliance 26710

Issued September 23, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 26710
Date: September 23, 2021
Company: AA Pharma Inc.Toronto, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Licensing Agreement Between Two Companies

Products in this notice

Brand	DIN	Status today
MEGESTROL	02195917	Marketed
MEGESTROL	02195925	Marketed

Medicinal ingredients

MEGESTROL ACETATE 40 MG per TAB
MEGESTROL ACETATE 160 MG per TAB